TI
PRCT icon

Trexquant Investment’s Procept Biorobotics PRCT Stock Holding History

Trexquant Investment’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.8M Buy
389,552
+16,152
+4% +$404K 0.05% 487
2026
Q1 		$9.34M Buy
373,400
+225,412
+152% +$6.35M 0.07% 396
2025
Q4 		$4.66M Buy
+147,988
New +$4.91M 0.04% 625
2025
Q3 		– Sell
-133,164
Closed -$7.67M – 1837
2025
Q2 		$7.67M Buy
133,164
+12,375
+10% +$700K 0.09% 361
2025
Q1 		$7.04M Buy
+120,789
New +$8.25M 0.08% 368
2024
Q3 		– Sell
-62,161
Closed -$3.8M – 1804
2024
Q2 		$3.8M Buy
62,161
+56,045
+916% +$3.33M 0.06% 493
2024
Q1 		$302K Buy
+6,116
New +$291K 0.01% 1284

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Trexquant Investment's PRCT Position: Q2 2026 in Review

Trexquant Investment increased its Procept Biorobotics (PRCT) stake by 4.3% in Q2 2026, buying an estimated $404K and bringing the position to 389,552 shares worth $8.8M. The position accounts for 0.05% of the portfolio, ranked #487.

Trexquant Investment first reported a position in PRCT in Q1 2024 and has held it in 7 quarters since. The position peaked at $9.34M in Q1 2026. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Trexquant Investment held 389,552 shares of Procept Biorobotics worth $8.8M as of Q2 2026.
  • Trexquant Investment bought 16,152 Procept Biorobotics shares in Q2 2026, an estimated $404K.
  • Procept Biorobotics made up 0.05% of Trexquant Investment's portfolio in Q2 2026, its #487 holding.
  • Trexquant Investment first reported a position in Procept Biorobotics in Q1 2024 and has held it in 7 quarters since.
  • Trexquant Investment's Procept Biorobotics position peaked at $9.34M in Q1 2026.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.